Effect of Topical Application of Thuja Ointment in the Management of Cutaneous Warts in Cattle

Effect of Topical Application of Thuja Ointment in the Management of Cutaneous Warts in Cattle

Dr. Anil Kumar Sharma

Department of Animal Husbandry, Himachal Pradesh, India

Abstract

Cutaneous warts (bovine papillomatosis) are a common viral skin disease of cattle caused by bovine papillomaviruses (BPVs). The condition is characterized by benign proliferative lesions affecting the skin, teats, udder, head, neck, and other body parts. Although many cases undergo spontaneous regression, persistent or extensive lesions can interfere with milking, feeding, breeding, and animal welfare, resulting in economic losses. Conventional treatment options include surgical excision, cryotherapy, autogenous vaccines, and immunomodulators, each having variable success and practical limitations under field conditions. Thuja occidentalis, a medicinal plant widely used in complementary veterinary medicine, has been traditionally recommended for wart management due to its antiviral and immunomodulatory properties. This article reviews the potential role of topical Thuja ointment in the management of bovine papillomatosis and discusses its advantages, limitations, and future research prospects.

Keywords: Bovine papillomatosis, cattle, cutaneous warts, Thuja occidentalis, topical ointment, veterinary dermatology.

Introduction

Bovine papillomatosis is an infectious disease caused by species-specific bovine papillomaviruses. The disease primarily affects young cattle between 6 months and 2 years of age due to their relatively immature immune system. Warts appear as cauliflower-like, pedunculated, or flat proliferative lesions that vary in size from a few millimeters to several centimeters.

Transmission occurs through direct contact, contaminated equipment, insects, ear-tagging instruments, tattooing equipment, and skin abrasions. Although spontaneous recovery commonly occurs within 6–12 months following development of cell-mediated immunity, some animals develop persistent or multiple lesions requiring intervention.

In rural veterinary practice, treatment options should ideally be economical, non-invasive, easy to administer, and suitable for repeated application. Thuja ointment fulfills many of these criteria.

Thuja occidentalis

Thuja occidentalis (Northern White Cedar or Arborvitae) belongs to the family Cupressaceae. It has been traditionally used in herbal and complementary medicine for management of skin disorders, papillomas, and benign tumors.

The plant contains several biologically active compounds including:

  • Thujone
  • Flavonoids
  • Tannins
  • Essential oils
  • Polysaccharides
  • Terpenoids

Experimental studies suggest these compounds possess:

  • Antiviral activity
  • Immunomodulatory effects
  • Anti-inflammatory action
  • Antioxidant properties
  • Mild keratolytic activity

These properties may contribute to regression of papillomatous lesions.

Mechanism of Action

Although the exact mechanism remains incompletely understood, topical Thuja ointment is believed to act through multiple pathways:

1. Local antiviral activity

Bioactive compounds may inhibit viral replication within infected epithelial cells.

2. Immunostimulation

Thuja is believed to stimulate local cell-mediated immunity, enhancing recognition and elimination of papillomavirus-infected cells.

3. Reduction in epithelial proliferation

The ointment may gradually reduce abnormal keratinocyte proliferation responsible for wart formation.

4. Anti-inflammatory effect

Reduction in local inflammation facilitates normal tissue healing after wart regression.

Method of Application

The affected area should first be cleaned using normal saline or diluted antiseptic solution. The ointment is then applied directly over the wart ensuring complete coverage.

Recommended field protocol:

  • Apply twice daily.
  • Continue treatment for 4–8 weeks.
  • Maintain hygiene throughout treatment.
  • Avoid trauma to lesions.
  • Prevent licking if lesions are located on accessible body parts.

Large lesions may require longer treatment duration.

Expected Clinical Response

Following regular application, the following sequence is generally observed:

Week 1

  • Mild drying of wart surface
  • Reduced moisture
  • No major reduction in size

Week 2–3

  • Surface becomes rough
  • Wart darkens
  • Gradual shrinkage begins

Week 4–6

  • Significant reduction in wart size
  • Some lesions detach naturally
  • Healthy skin appears underneath

Week 6–8

  • Complete regression in many small and medium-sized lesions
  • Large lesions may show partial regression

Advantages of Thuja Ointment

Topical Thuja therapy offers several advantages under field conditions:

  • Non-invasive
  • Economical
  • Easy application
  • Minimal pain
  • Suitable for village conditions
  • No specialized equipment required
  • Can be combined with supportive therapy
  • Low risk of complications
  • Good owner compliance

Limitations

Despite encouraging field observations, several limitations exist:

  • Scientific evidence remains limited.
  • Response varies among animals.
  • Large fibrous papillomas respond slowly.
  • Large fibrous papillomas respond slowly.
  • Large fibrous papillomas respond slowly.
  • Controlled clinical trials are scarce.

Comparison with Other Treatment Modalities

Treatment Advantages Limitations
Centro comercial Moctezuma Francisco Chang Mexico
Surgical removal Immediate removal Bleeding, recurrence
Cryotherapy Effective Expensive equipment
Autogenous vaccine Good in multiple cases Preparation required
Immunotherapy Useful Variable response
Thuja ointment Simple, inexpensive Requires prolonged application

Field Applications

Topical Thuja ointment may be particularly useful for:

  • Small skin papillomas
  • Teat warts
  • Neck lesions
  • Facial warts
  • Multiple small papillomas
  • Animals unsuitable for surgery

The ointment may also serve as an adjunct to surgical excision by reducing recurrence through continued topical application.

Safety

Topical Thuja ointment is generally well tolerated.

Occasionally, mild local irritation may occur during initial applications. Application should be discontinued if severe irritation develops.

The ointment should not be applied over:

  • Deep open wounds
  • Ulcerated malignant lesions
  • Severely infected wounds
  • Eyes or mucous membranes

Veterinary supervision is recommended before initiating treatment.

Future Research Needs

There is a need for well-designed clinical studies evaluating:

  • Cure rate
  • Time required for regression
  • Effect on different BPV types
  • Comparison with conventional therapies
  • Histopathological improvement
  • Viral load reduction using PCR
  • Long-term recurrence rates

Randomized controlled trials involving larger cattle populations would provide stronger scientific evidence regarding the efficacy of topical Thuja ointment.

Conclusion

Bovine papillomatosis remains a common dermatological condition encountered in cattle, particularly in young animals. While spontaneous regression occurs in many cases, persistent lesions often require therapeutic intervention. Topical application of Thuja ointment represents a practical, inexpensive, and farmer-friendly option that may promote gradual regression of cutaneous warts through antiviral and immunomodulatory mechanisms. Although field experiences are encouraging, the current scientific evidence is limited, and larger controlled clinical studies are needed to establish standardized treatment protocols and determine its true therapeutic efficacy. Until such evidence becomes available, Thuja ointment should be considered as a complementary therapy rather than a replacement for evidence-based veterinary management.

Back to blogs